Clinical Trial Update: Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating multiparametric metabolic and hypoxic PET/MRI for disease assessment in high-grade glioma. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: High Grade Glioma | EARLY_Phase 1 | Status: RECRUITING